iOrganBio: Valuation, Funding & Investors
iOrganBio is transforming human cell production with CellForge, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles.
Leadership & Board
- Current Number of Employees
- 23
- Current LinkedIn Followers
- 3,709
Latest Estimated Valuation
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Investment
Company Momentum
PositiveiOrganBio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
iOrganBio had 23 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
iOrganBio had 3,709 followers as of November 16, 2026. The number of followers increased by 26 (0.71%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 29, 2025 | Investment | $2.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| First Star Ventures | Investment |
| IndieBio | Investment |
| Cape Fear BioCapital | Investment |
| 2ndF | Investment |
| Terasaki Institute | Investment |
| Alix Ventures | Investment |
Similar Companies
A snapshot of private companies similar to iOrganBio, helping you discover and navigate related company profiles.
Related News and Analysis









